Growth Metrics

TELA Bio (TELA) Preferred Stock Liabilities (2018 - 2019)

TELA Bio has reported Preferred Stock Liabilities over the past 2 years, most recently at $1.6 million for Q3 2019.

  • For Q3 2019, Preferred Stock Liabilities fell 94.97% year-over-year to $1.6 million; the TTM value through Sep 2019 reached $1.6 million, down 94.97%, while the annual FY2018 figure was $124.2 million, 54.4% up from the prior year.
  • Preferred Stock Liabilities for Q3 2019 was $1.6 million at TELA Bio, down from $107.1 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $124.2 million in Q4 2018 and troughed at $1.6 million in Q3 2019.